Baker Bros. Advisors LP

SEC CIK: 0001263508
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

DNLI holding history

Denali Therapeutics Inc. in every 13F filed by Baker Bros. Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNLI overview All 13F holders of DNLI Full Q2 2026 holdings

Shares (Q2 2026): 3,734,336
Value: $96.0M
% of portfolio: 0.5%
Quarters held: 22; Since Q1 2021

Holdings of DNLI by Baker Bros. Advisors LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	3,734,336	$96.0M	0.5%	+2,641+0.1%	Added	Holders
Q1 2026	3,731,695	$71.6M	0.4%	00.0%	Unchanged	Holders
Q4 2025	3,731,695	$61.6M	0.4%	00.0%	Unchanged	Holders
Q3 2025	3,731,695	$54.2M	0.4%	00.0%	Unchanged	Holders
Q2 2025	3,731,695	$52.2M	0.5%	00.0%	Unchanged	Holders
Q1 2025	3,731,695	$50.7M	0.6%	00.0%	Unchanged	Holders
Q4 2024	3,731,695	$76.1M	0.8%	00.0%	Unchanged	Holders
Q3 2024	3,731,695	$108.7M	1.1%	00.0%	Unchanged	Holders
Q2 2024	3,731,695	$86.6M	1.1%	00.0%	Unchanged	Holders
Q1 2024	3,731,695	$76.6M	1.0%	+1,124,499+43.1%	Added	Holders
Q4 2023	2,607,196	$56.0M	0.6%	+315,193+13.8%	Added	Holders
Q3 2023	2,292,003	$47.3M	0.3%	+836,681+57.5%	Added	Holders
Q2 2023	1,455,322	$42.9M	0.2%	+366,584+33.7%	Added	Holders
Q1 2023	1,088,738	$25.1M	0.1%	00.0%	Unchanged	Holders
Q4 2022	1,088,738	$30.3M	0.2%	+500,000+84.9%	Added	Holders
Q3 2022	588,738	$18.1M	0.1%	00.0%	Unchanged	Holders
Q2 2022	588,738	$17.3M	0.1%	+500,000+563.5%	Added	Holders
Q1 2022	88,738	$2.85M	<0.1%	00.0%	Unchanged	Holders
Q4 2021	88,738	$3.96M	<0.1%	00.0%	Unchanged	Holders
Q3 2021	88,738	$4.48M	<0.1%	00.0%	Unchanged	Holders
Q2 2021	88,738	$6.96M	<0.1%	00.0%	Unchanged	Holders
Q1 2021	88,738	$5.07M	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.